These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26323994)

  • 1. Rectal Cancer: Time for Precision Medicine?
    Weiser MR
    Ann Surg Oncol; 2016 Jan; 23(1):12-5. PubMed ID: 26323994
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: Toward Molecularly-Driven Personalized Care for Young Adults with Rectal Cancer.
    Yang Y; You YN
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):656-657. PubMed ID: 31297673
    [No Abstract]   [Full Text] [Related]  

  • 3. Biomarkers to tailor chemoradiation therapies.
    Guzzetta AA; Ahuja N
    J Surg Res; 2012 Apr; 173(2):243-5. PubMed ID: 21435667
    [No Abstract]   [Full Text] [Related]  

  • 4. Next-generation, genome- and mutational landscape heterogeneity-based novel biomarkers for personalized neoadjuvant treatment and laparoscopic rectal cancer resection.
    Hottenrott C
    Surg Endosc; 2013 Apr; 27(4):1441-3. PubMed ID: 23052542
    [No Abstract]   [Full Text] [Related]  

  • 5. Lack of access to targeted cancer therapy.
    Burki TK
    Lancet Oncol; 2015 Oct; 16(13):e482. PubMed ID: 26321211
    [No Abstract]   [Full Text] [Related]  

  • 6. Next-Generation Sequencing in Oncology in the Era of Precision Medicine.
    Blumenthal GM; Mansfield E; Pazdur R
    JAMA Oncol; 2016 Jan; 2(1):13-4. PubMed ID: 26540172
    [No Abstract]   [Full Text] [Related]  

  • 7. How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy.
    Farwell MD; Clark AS; Mankoff DA
    JAMA Oncol; 2015 Jul; 1(4):421-2. PubMed ID: 26181243
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and molecular diagnosis of pathologic complete response in rectal cancer.
    Patel PM; Harris K; Huerta S
    Expert Rev Mol Diagn; 2015; 15(11):1505-16. PubMed ID: 26415019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs as biomarkers of multimodal treatment for rectal cancer.
    Waldron RM; Moloney BM; Gilligan K; Lowery AJ; Joyce MR; Holian E; Kerin MJ; Miller N
    Br J Surg; 2021 Aug; 108(8):e260-e261. PubMed ID: 33880499
    [No Abstract]   [Full Text] [Related]  

  • 10. Using Somatic Mutations to Guide Treatment Decisions: Context Matters.
    Horlings HM; Shah SP; Huntsman DG
    JAMA Oncol; 2015 Jun; 1(3):275-6. PubMed ID: 26181166
    [No Abstract]   [Full Text] [Related]  

  • 11. Precision medicine: lessons learned from the SHIVA trial.
    Weiss GJ
    Lancet Oncol; 2015 Dec; 16(16):e580. PubMed ID: 26678199
    [No Abstract]   [Full Text] [Related]  

  • 12. Precision medicine: lessons learned from the SHIVA trial.
    Hahn AW; Martin MG
    Lancet Oncol; 2015 Dec; 16(16):e580-1. PubMed ID: 26678198
    [No Abstract]   [Full Text] [Related]  

  • 13. Precision medicine: lessons learned from the SHIVA trial.
    Tsimberidou AM; Kurzrock R
    Lancet Oncol; 2015 Dec; 16(16):e579-80. PubMed ID: 26678197
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular profiles in foregut oncology.
    Sukharamwala P; Hennessey D; Wood T; Singh S; Ryan C; Rosemurgy A
    Cancer Genet; 2016 Dec; 209(12):537-553. PubMed ID: 27887938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precision medicine: lessons learned from the SHIVA trial - Authors' reply.
    Le Tourneau C; Belin L; Paoletti X; Bièche I; Kamal M
    Lancet Oncol; 2015 Dec; 16(16):e581-2. PubMed ID: 26678200
    [No Abstract]   [Full Text] [Related]  

  • 16. Personalising the treatment of prostate cancer.
    Gunjur A
    Lancet Oncol; 2015 Dec; 16(16):e592. PubMed ID: 26549591
    [No Abstract]   [Full Text] [Related]  

  • 17. Advances in radiotherapy and targeted therapies for rectal cancer.
    Sermeus A; Leonard W; Engels B; De Ridder M
    World J Gastroenterol; 2014 Jan; 20(1):1-5. PubMed ID: 24415852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoma of Unknown Primary Site: The Poster Child for Personalized Medicine?
    Varadhachary G
    JAMA Oncol; 2015 Apr; 1(1):19-21. PubMed ID: 26182299
    [No Abstract]   [Full Text] [Related]  

  • 19. Genomic Profiling of Cancers of Unknown Primary Site--Reply.
    Ross JS; Miller VA; Stephens PJ
    JAMA Oncol; 2015 Jul; 1(4):542-3. PubMed ID: 26181269
    [No Abstract]   [Full Text] [Related]  

  • 20. Genomic Profiling of Cancers of Unknown Primary Site: The Next Steps.
    Cobain EF; Chinnaiyan AM; Kurzrock R; Baker LH
    JAMA Oncol; 2015 Jul; 1(4):542. PubMed ID: 26181268
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.